1 – 15 of 22
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Combined Connectomics, MAPT Gene Expression, and Amyloid Deposition to Explain Regional Tau Deposition in Alzheimer Disease
(
- Contribution to journal › Article
-
Mark
COMBAT-MS : A Population-Based Observational Cohort Study Addressing the Benefit–Risk Balance of Multiple Sclerosis Therapies Compared with Rituximab
2024) In Annals of Neurology(
- Contribution to journal › Article
-
Mark
Head-to-Head Comparison of Tau and Amyloid Positron Emission Tomography Visual Reads for Differential Diagnosis of Neurodegenerative Disorders : An International, Multicenter Study
(
- Contribution to journal › Article
- 2022
-
Mark
Effect Modification between Genes and Environment and Parkinson's Disease Risk
(
- Contribution to journal › Scientific review
- 2021
-
Mark
DNase Treatment Prevents Cerebrospinal Fluid Block in Early Experimental Pneumococcal Meningitis
(
- Contribution to journal › Article
- 2020
-
Mark
Midlife Atherosclerosis and Development of Alzheimer or Vascular Dementia
(
- Contribution to journal › Article
-
Mark
Plasma NT1 Tau is a Specific and Early Marker of Alzheimer's Disease
(
- Contribution to journal › Article
-
Mark
Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients
(
- Contribution to journal › Article
-
Mark
Genetically Elevated LDL Associates with Lower Risk of Intracerebral Hemorrhage
(
- Contribution to journal › Article
- 2019
-
Mark
Using global team science to identify genetic parkinson's disease worldwide
(
- Contribution to journal › Article
- 2017
-
Mark
Serum tau and neurological outcome in cardiac arrest
(
- Contribution to journal › Article
-
Mark
Sensation, mechanoreceptor, and nerve fiber function after nerve regeneration
(
- Contribution to journal › Article
-
Mark
Genetic variation at 16q24.2 is associated with small vessel stroke
(
- Contribution to journal › Article
- 2009
-
Mark
Reply
(
- Contribution to journal › Letter
- 2008
-
Mark
Yield of additional metabolic studies in neurodevelopmental disorders
(
- Contribution to journal › Article